Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

The push to cut drug prices is one of those rare hot-button issues that unites the two major political parties.

Previous post Under Armour shares jump after it raises profit expectations amid sliding sales
Next post Westfield mall operator resumes dividends with vacancies, rent collection back at pre-COVID levels